Genedata Expands Affymetrix GeneChip-compatibleTM Status for Exon Expression on GeneChip® Microarray Platform

Genedata, a leading provider of in silico solutions for the pharmaceutical and life sciences industries, today announced that its Expressionist platform has expanded GeneChip-compatible™ status for Exon expression with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform.

Source: Genedata AG